Spastic Ataxia Composite ( SPAXCOM ): A Scale to Evaluate the Progression of Subjects with Spasticity and Ataxia
Movement Disorders · 2025-11 · 40 (11) · 2476-2485
DOI: 10.1002/mds.70006 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Movement Disorders, online erschienen am 20.08.2025. Verfasst von Cécile Di Folco und 23 weiteren Autor:innen. Beteiligte Einrichtung: Sorbonne Université, Institut du Cerveau-Paris Brain Institute-ICM, CNRS, Inria, Inserm, AP-HP, Groupe Hospitalier Sorbonne Université, Paris, France. Hauptthemen laut MEDLINE: Muscle Spasticity, Disease Progression, Spinocerebellar Ataxias, Severity of Illness Index. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Medical Research Council, ZonMw, Bundesministerium für Bildung und Forschung.
Abstract (Originalsprache)
Background
Current clinical scales that track disease progression are more tailored to spasticity or ataxia, with limited sensitivity to change.
Objectives
The aim was to develop a sensitive and valid scale specifically geared towards optimized sensitivity to change and adapted to patients presenting with both spasticity and ataxia.
Methods
Longitudinal data from 127 spastic paraplegia type 7 (SPG7) and 112 autosomal recessive spastic ataxia Charlevoix‐Saguenay (ARSACS) patients were collected within the multicenter PROSPAX study. Sensitivity to change over 2 years of 30 items from the Scale for the Rating and Assessment of Ataxias (SARA), Spastic Paraplegia Rating Scale (SPRS), and the Activities of Daily Living subscale of the Friedreich's Ataxia Rating Scale (FARS‐ADL) was evaluated. Items that demonstrated the highest sensitivity to change were used to build the Spastic Ataxia Composite scale (SPAXCOM).
Results
With seven items, the SPAXCOM showed an effect size of 0.71, higher than reference scales (SARA: 0.43, SPRS: 0.42, FARS‐ADL: 0.27). The SPAXCOM had a similar sensitivity to change for both genotypes and was more sensitive in participants with a SARA lower than 10 and within the intermediate disease stage (FARS‐Disease Staging: 2–3.5). The SPAXCOM showed a high correlation with disease duration ( r = 0.67 [0.60; 0.72]) and disease stage ( r = 0.86 [0.83; 0.89]). Perception of improvement, stagnation, and worsening were associated with a mean yearly SPAXCOM change of 0.44 (−0.14; 1.01), 0.61 (0.19; 1.03), and 1.22 (0.96; 1.49), respectively.
Conclusion
The SPAXCOM is more sensitive to change and homogeneous across genotypes than the reference scales, allowing a reduction of the required sample size in future clinical trials. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Sorbonne Université, Institut du Cerveau-Paris Brain Institute-ICM, CNRS, Inria, Inserm, AP-HP, Groupe Hospitalier Sorbonne Université, Paris, France.
- Center for Neurology and Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
- Groupe de Recherche Interdisciplinaire Sur Les Maladies Neuromusculaires (GRIMN), Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay-Lac-St-Jean, Saguenay, Quebec, Canada.
- Faculté de médecine et des sciences de la santé, Université de Sherbrooke, Sherbrooke, Quebec, Canada.
- Centre ÉCOBES-Recherche et Transfert, Cégep de Jonquière, Saguenay, Quebec, Canada.
- Centre Intégré Universitaire de Santé et de Services Sociaux de la Capitale Nationale, Québec City, Quebec, Canada.
ORCID-Profile: Andreas Traschütz, Cynthia Gagnon, Sirio Cocozza, Sara Satolli, Filippo M Santorelli, Ilse H J Willemse, A Nazli Başak, Matthis Synofzik, Sophie Tezenas du Montcel
Förderung
- National Medical Research Council
- ZonMw
- Bundesministerium für Bildung und Forschung
- Agence Nationale de la Recherche
- Addenbrookes Charitable Trust
- Ministero della Salute
- Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)
- European Reference Network for Rare Neurological Diseases
Zitieren
APA
Di Folco, C., Dubec-Fleury, C., Traschütz, A., Kessler, C., Reich, S., Gagnon, C., Lessard, I., Rodrigue, X., Cocozza, S., Satolli, S., Santorelli, F. M., Durr, A., Heinzmann, A., van de Warrenburg, B. P., Willemse, I. H. J., Başak, A. N., Vural, A., Brais, B., Klebe, S., …, & Tezenas du Montcel, S. (2025). Spastic Ataxia Composite ( SPAXCOM ): A Scale to Evaluate the Progression of Subjects with Spasticity and Ataxia. Movement Disorders, 40(11), 2476-2485. https://doi.org/10.1002/mds.70006
Vancouver
Di Folco C, Dubec-Fleury C, Traschütz A, Kessler C, Reich S, Gagnon C, et al. Spastic Ataxia Composite ( SPAXCOM ): A Scale to Evaluate the Progression of Subjects with Spasticity and Ataxia. Movement Disorders. 2025;40(11):2476-2485. doi:10.1002/mds.70006
BibTeX
@article{DiFolco2025,
author = {Di Folco, Cécile and Dubec-Fleury, Charlotte and Traschütz, Andreas and Kessler, Christoph and Reich, Selina and Gagnon, Cynthia and Lessard, Isabelle and Rodrigue, Xavier and Cocozza, Sirio and Satolli, Sara and Santorelli, Filippo M and Durr, Alexandra and Heinzmann, Anna and van de Warrenburg, Bart P and Willemse, Ilse H J and Başak, A Nazli and Vural, Atay and Brais, Bernard and Klebe, Stephan and Horvath, Rita and PROSPAX Consortium, PROSPAX Consortium and Schüle, Rebecca and Synofzik, Matthis and Tezenas du Montcel, Sophie},
title = {Spastic Ataxia Composite ( SPAXCOM ): A Scale to Evaluate the Progression of Subjects with Spasticity and Ataxia},
journal = {Movement Disorders},
year = {2025},
volume = {40},
number = {11},
pages = {2476--2485},
doi = {10.1002/mds.70006}
}
EUVIMED